FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Original Application (Sigmapharm Laboratories, LLC)

View source ↗

Summary

FDA approved the original application (ANDA) for ULTRAMICROSIZE GRISEOFULVIN from Sigmapharm Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis
• Tinea Capitis
• Tinea Corporis
• Tinea Cruris
• Tinea Pedis

Drugs mentioned

• ULTRAMICROSIZE GRISEOFULVIN (griseofulvin)

Snippet

ORIG AP for ULTRAMICROSIZE GRISEOFULVIN (ULTRAMICROSIZE GRISEOFULVIN)